Bharat Bio hopes to soon submit trial data for intranasal vaccine

Bharat Bio hopes to soon submit trial data for intranasal vaccine "The trials are ongoing, and we expect to submit data by the end of this year," a company insider said. The trials, including over 600 participants, are being conducted by dividing the volunteers into three groups. https://ift.tt/eA8V8J